2719-MSM1-P0
antibody from Invitrogen Antibodies
Targeting: GPC3
DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1
Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 2719-MSM1-P0 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) Monoclonal Antibody (1G12)
- Antibody type
- Monoclonal
- Antigen
- Recombinant protein fragment
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 1G12
- Vial size
- 20 µg
- Concentration
- 200 µg/mL
- Storage
- 4° C, do not freeze
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of HePG2 cell lysate using Glypican-3 Monoclonal Antibody (1G12).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescence analysis of MeOH-fixed HepG2 cells labeling Glypican-3 with Glypican-3 Monoclonal Antibody (1G12) followed by Goat anti-Mouse IgG-CF488 (Green). The nuclear counterstain is Reddot (Red).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Formalin-fixed, paraffin-embedded human Hepatocellular Carcinoma (HCC) stained with Glypican-3 Monoclonal Antibody (1G12).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Flow Cytometric analysis of MeOH-fixed HepG2 cells using Glypican-3 Monoclonal Antibody (1G12) followed by Goat anti- Mouse- IgG-CF488 (Blue); Isotype Control (Red).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- SDS-PAGE of Purified Glypican-3 Monoclonal Antibody (1G12). Confirmation of Integrity and Purity of Antibody.